- Report
- December 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- September 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- September 2021
- 40 Pages
China
From €2366EUR$2,600USD£2,029GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Ranitidine is a medication used to treat gastrointestinal disorders, such as heartburn, acid reflux, and ulcers. It is a histamine-2 blocker, which works by reducing the amount of acid produced in the stomach. Ranitidine is available in both prescription and over-the-counter forms. It is commonly used to treat symptoms of gastroesophageal reflux disease (GERD) and other gastrointestinal disorders.
Ranitidine is one of the most widely used medications for gastrointestinal disorders. It is available in a variety of forms, including tablets, capsules, and liquids. It is also available in combination with other medications, such as antacids and proton pump inhibitors. Ranitidine is generally well-tolerated and has few side effects.
The market for ranitidine is highly competitive, with many companies offering generic and branded versions of the medication. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more